HCEG Healthcare Ent.

RNS Number:7905L
Healthcare Enterprise Group PLC
08 November 2006

8 November 2006


Healthcare Enterprise Group PLC
(the "Company")


Issue of shares


Firm Placing


Further to the announcement made on 2 November 2006, the Firm Placing (as
further described in such announcement) is now complete.

Accordingly 6,666,667 ordinary shares of 2.5 pence each in the Company 
("Ordinary Shares") were admitted to trading on AIM this morning.


Of these shares, Directors of the Company or their connected persons subscribed
for 3,333,333 Ordinary Shares at 3 pence per share as follows:


            Mr Lyndon Gaborit          -             833,333

            Mr Mark Tompkins           -             833,333

            Mr Nigel Wray              -           1,666,667.


Non-Executive Directors Share Issues

In addition, in relation to the provision of services as non-executive
directors, the Company has allotted Ordinary Shares on 8 November 2006 (at the
mid-market closing price on 7 November 2006 of 3.38p per share) in satisfaction
of professional fees as follows:

            Mr Nicholas Brigstocke - 133,136 Ordinary Shares in the Company 
            (at 3.38p per share);

            Mr Mark Tompkins - 133,136 Ordinary Shares in the Company 
            (at 3.38p per share); and

            Mr Nigel Wray - 133,136 Ordinary Shares in the Company 
            (at 3.38p per share).


The shares are expected to be admitted to trading on AIM on 15 November 2006.



Exercise of Options



In addition, the Company announces that a total of 1,520,681 new Ordinary Shares
have been issued and allotted, pursuant to the Company's share option scheme, on
8 November 2006.



The optionholders exercising options were as follows:

            Mr Nicholas Brigstocke (a non-executive director of the Company) -
            113,246 Ordinary Shares in the Company (at 2.5p per share);

            Mr Ken Denos (formerly an executive director of the Company) -
            199,476 Ordinary Shares in the Company (at 2.5p per share); and

            Mr Michael Low (formerly an executive director of the Company) -
            1,207,959 Ordinary Shares in the Company (at 2.5p per share).



The shares are expected to be admitted to trading on AIM on 15 November 2006.





Directors' Shareholdings



The resulting holdings of the Directors are as follows:


Director                Overall       Number of         Percentage of issued share capital as enlarged
                        number of new Ordinary Shares   by the Placing (assuming the shareholder
                        Ordinary      held following    resolutions at the EGM on 27 November are
                        Shares        the Placing and   passed and the Conditional Placing Shares, as
                        acquired      shares issues     further described in the 2 November
                                      notified in this  announcement, are all allotted)
                                      announcement

Nicholas Brigstocke       246,382      2,072,186        0.76


Lyndon Gaborit            833,333      1,053,351        0.38


Mark Tompkins             966,469      1,274,409        0.47


Nigel Wray              1,799,803     17,222,057        6.32


Total                   3,845,987     21,622,003        7.93







Fertiloscopy



Further to previous announcements about the restructuring and scaling back on
capital expenditure, the Group's decision not to proceed with the Fertiloscopy
project has resulted in the issue, on 8 November 2006, of 1,008,428 ordinary
shares of 2.5p each in the Company in respect of the closure of matters relating
to Fertiloscopy, at a (five preceding days mid-market closing) price of 3.322
pence per share.



The shares are expected to be admitted to trading on AIM on 15 November 2006.





Total Issued Share Capital



The Company's issued share capital at this time is 212,483,387 ordinary shares
of 2.5 pence each.





Conditional Placing and amendment to warrant terms



As set out in the announcement on 2 November 2006, a further 60,000,000 ordinary
shares have been placed on a conditional basis. Subsequent to that, the issued
share capital of the Company (subject to any further allotments) would be
272,483,387 Ordinary Shares.



The conditions include, among other things, the passing by shareholders at an
EGM to be held on 27 November 2006 of a resolution to give the Directors
authority to allot shares up to an agreed limit and to dis-apply statutory
pre-emption rights on allotments of shares.



As further described in the 2 November announcement, subject to the passing of
resolutions at the EGM and warrantholders meeting on 27 November, the Company
will allot warrants (on a 1 for 4 basis) to placees under the Placing, and amend
the terms of the existing warrants in issue.



Enquiries:

College Hill                                            020 7457 2020
Adrian Duffield / Corinna Dorward




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

IOEDVLFBQFBEFBE

Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jun 2024 to Jul 2024

Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jul 2023 to Jul 2024